2015 Annual Meeting: Immunology On Demand
You can earn up to 9.25 AMA PRA Category 1 Credit(s)™. This activity has also been designated by the ABAI for 3.5 MOC Part II Self-Assessment credits. Cost:
$185 $95 for College Members, $279 $139 for non-members.
This package of courses includes the following immunology related sessions from the 2015 ACAAI Annual Meeting in San Antonio:
- Human Microbiome: The Interface of Immunology and Microbiology
- Managing Non-Infectious Complications of Common Variable Immunodeficiency
- Altering the Natural History of Allergic Diseases With Immunotherapy
- W20 Are You Ready for SCID Newborn Screening?
- W29 Immunotherapy in 2015: The Nuts and Bolts of SCIT and SLIT
Release Date: 12/15/2015
Expiration Date: 12/14/2018
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 9.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is not supported by commercial interests.
• Discuss facets of modulation of gut microbiota that lead to disruption of host-microorganism homeostasis and contributes to the development of non-communicable inflammatory diseases
• Explain how gut microbiota dysbiosis contributes to aberrant immune development and the development of allergic disease and asthma
• Discuss the implications of gut microbiota modification for treatment and prevention of allergic disease and asthma
• Recognize and treat the pulmonary complications of common variable immunodeficiency
• Recognize and treat the autoimmune complications of common variable immunodeficiency
• Describe malignancies associated with common variable immunodeficiency diseases
• Recognize the similarities and differences in logistics, efficacy, and safety of SLIT and SCIT for inhalant allergies
• Discuss results of recent food allergy immunotherapy clinical trials
• Discuss likely future strategies for performing immunotherapy, including using adjuvants, biologicals, and peptides
• Recognize the important steps for implementing statewide SCID newborn screening; and discuss the basis of TREC screening, including the conditions identified by this test, and the proper next steps to be taken after an abnormal newborn screening test
• Explain the differences between standardized and nonstandardized extracts
• Compose a therapeutic mix for immunotherapy through review of the literature
• Write prescriptions for immunotherapy which contain safe and effective doses of each component according to current guidelines and best clinical practice for the benefit of patient care
• Use current guidelines to improve the safety and effectiveness of immunotherapy in the office
• Explore the literature regarding SLIT
• Explore adherence to IT
- 9.25 AMA PRA Category 1 Credit™
- 9.25 Attendance
- 3.50 MOC